SLNSW-Biomarker and Histopathology Evaluation of Patien...-TN_cdi_proquest_journals_1910599071

Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

Full title: Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

Author/creator: Capper, David, von Deimling, Andreas, Brandes, Alba A, Carpentier, Antoine F, Kesari, Santosh, Sepulveda-Sanchez, Juan M, Wheeler, Helen R, Chinot, Olivier, Cher, Lawrence, Steinbach, Joachim P, Specenier, Pol, Rodon, Jordi, Cleverly, Ann, Smith, Claire, Gueorguieva, Ivelina, Miles, Colin, Guba, Susan C, Desaiah, Durisala, Estrem, Shawn T, Lahn, Michael M, Wick, Wolfgang.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_1910599071

Language: English

Formats: Articles

Publishers: Switzerland: MDPI AG

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1910599071

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

    Record identifier

    TN_cdi_proquest_journals_1910599071

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1910599071

    Share

    Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1910599071

    Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

    Full title

    Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine

    Author / Creator

    Capper, David ; von Deimling, Andreas ; Brandes, Alba A ; Carpentier, Antoine F ; Kesari, Santosh ; Sepulveda-Sanchez, Juan M ; Wheeler, Helen R ; Chinot, Olivier ; Cher, Lawrence ; Steinbach, Joachim P ; Specenier, Pol ; Rodon, Jordi ; Cleverly, Ann ; Smith, Claire ; Gueorguieva, Ivelina ; Miles, Colin ; Guba, Susan C ; Desaiah, Durisala ; Estrem, Shawn T ; Lahn, Michael M ; Wick, Wolfgang

    Publisher

    Switzerland: MDPI AG

    Journal title

    International journal of molecular sciences, 2017, Vol.18 (5), p.995

    Record Identifier

    TN_cdi_proquest_journals_1910599071

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Adult Antineoplastic Combined Chemotherapy Protocols Assessments Biomarkers Biomarkers, Tumor - blood Biomarkers, Tumor - metabolism CCL22 protein CD3 antigen CD4 antigen CD4-CD8 Ratio CD8 antigen CDK4 CDK6 Chemokines Cytokines - blood Cytoplasm Enzyme inhibitors Eosinophils Female Forkhead Transcription Factors - blood Forkhead Transcription Factors - metabolism Foxp3 protein galunisertib monohydrate (LY2157299) Glial fibrillary acidic protein Glioblastoma Glioblastoma - blood Glioblastoma - drug therapy Glioblastoma - pathology Histopathology Humans Inhibitors Isocitrate dehydrogenase Isocitrate Dehydrogenase - metabolism Kinases Leukocytes (eosinophilic) Lomustine - administration & dosage Lomustine - adverse effects Lomustine - therapeutic use Lymphocytes Lymphocytes T Macrophages Male Markers Neoplasm Recurrence, Local - blood Neoplasm Recurrence, Local - drug therapy Neoplasm Recurrence, Local - pathology Pathology Patients Pharmacodynamics Pharmacology Plasmas (physics) pSMAD2 Pyrazoles - administration & dosage Pyrazoles - adverse effects Pyrazoles - therapeutic use Quinolines - administration & dosage Quinolines - adverse effects Quinolines - therapeutic use Smad2 Protein - metabolism Survival Survival Analysis TGF-β Therapy Transforming growth factor-a Tumors

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_1910599071

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1910599071

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections